Orthopedics
Extended thromboprophylaxis recommended after hip or knee replacement
Published in Blood Weekly, April 3rd, 2003
"Early discharge from the hospital after total joint arthroplasty has increased the need for extended outpatient thromboprophylaxis. Multiple controlled clinical trials and several meta-analyses of these data have examined various agents in different regimens. These data indicate that extended prophylaxis with a low-molecular-weight heparin after knee or hip arthroplasty significantly reduces the number of venous thromboembolic episodes with no increases in major bleeding," wrote R.J. Friedman and colleagues.
They...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2003-04-03)
More Articles from Blood Weekly
- Multiple Sclerosis
Autologous stem cell transplantation can be beneficial - Stem Cell Transplantation
Donor pretreatment with IL-18 prevents acute GVHD - Epidemiology
Drug use and blood products transmit hepatitis C virus infections in Uzbekistan - HIV/AIDS Therapy
Different blood cell types have varying drug resistance rates - Stem Cell Research
Transplanted bone marrow generates new neurons in human brains - Acute Lymphoblastic Leukemia
Bone marrow grafts may be best option with matched unrelated donors - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
